Therapeutic drug monitoring guides personalized ponatinib dose reduction for chronic myeloid leukemia. Abumiya M, Takahashi N. Int J Hematol 2026 Jul 14. doi: 10.1007/s12185-026-04254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abumiya M, Takahashi N. Therapeutic drug monitoring guides personalized ponatinib dose reduction for chronic myeloid leukemia. Int J Hematol 2026 Jul 14. doi: 10.1007/s12185-026-04254.
PMID: 42449088